Department of Pharmacology, University of California, San Diego, La Jolla, California 92093, USA.
Bioconjug Chem. 2010 Oct 20;21(10):1811-9. doi: 10.1021/bc1001328.
We combine a novel boronate trap for F(-) with a near-infrared fluorophore into a single molecule. Attachment to targeting ligands enables localization by positron emission tomography (PET) and near-infrared fluorescence (NIRF). Our first application of this generic tag is to label Lymphoseek (tilmanocept), an agent designed for receptor-specific sentinel lymph node (SLN) mapping. The new conjugate incorporates (18)F(-) in a single, aqueous step, targets mouse SLN rapidly (1 h) with reduced distal lymph node accumulation, permits PET or scintigraphic imaging of SLN, and enables NIRF-guided excision and histological verification even after (18)F decay. This embodiment is superior to current SLN mapping agents such as nontargeted [(99m)Tc]sulfur colloids and Isosulfan Blue, as well as the phase III targeted ligand [(99m)Tc]SPECT Lymphoseek counterpart, species that are visible by SPECT or visible absorbance separately. Facile incorporation of (18)F into a NIRF probe should promote many synergistic PET and NIRF combinations.
我们将一种新型硼酸盐陷阱与近红外荧光团结合到一个单一的分子中。与靶向配体的结合可通过正电子发射断层扫描(PET)和近红外荧光(NIRF)进行定位。我们首次将这种通用标签应用于标记 Lymphoseek(替拉诺塞),这是一种专为受体特异性前哨淋巴结(SLN)定位设计的试剂。新的缀合物在单个水性步骤中掺入(18)F(-),以减少远端淋巴结积累的方式快速靶向小鼠 SLN(1 小时),允许 PET 或闪烁成像进行 SLN 成像,并在(18)F 衰变后允许进行 NIRF 引导切除和组织学验证。与目前的 SLN 定位剂(如非靶向[99m]Tc 硫胶体和异硫蓝)以及 III 期靶向配体[99m]Tc SPECT Lymphoseek 相比,这种方法具有优越性,后者可通过 SPECT 或可见吸收率分别进行显影。(18)F 很容易掺入到近红外荧光探针中,应该会促进许多协同的 PET 和 NIRF 组合。